Abstract
Background In April 2014 the Centers for Medicare and Medicaid Services (CMS) released a dataset for the public which included information on services provided by physicians and healthcare providers for Medicare beneficiaries in the 2012 calendar year. The objective of this study is to determine spine surgeons’ opinions on the release of the CMS data, and determine how they feel this information may affect patient care.
Methods A survey was sent to members of the Association for Collaborative Spine Research (ACSR) regarding their practice patterns and opinions on the release of the CMS data. Determinants included surgical subspecialty, practice setting, years in practice and region. The average response was collected for each question and compared across groups. Additionally, questions in which greater than 75% of respondents either agreed (agree or strongly agree) or disagreed (disagree or strongly disagree) were identified.
Results Seventy-six surgeons completed the survey, and while the overall interobserver reliability between each question was only slight (κ = 0.11), more than 75% of respondents either agreed or strongly agreed with five statements and, more than 75% of respondents either disagreed or strongly disagreed with six statements. While 86% of surgeons are in favor of more transparency, 83% of respondents felt that without the proper context, the data released does not accurately portray spine surgery. Additionally, 96% of spine surgeons do not believe the CMS data helps patients decide which spine surgeon is best for them.
Conclusions The small percentage of spine surgeons who responded to this survey are in favor of more transparency but do not feel the release of the CMS data either accurately represents spine surgeons or will help patients better identify the appropriate surgeon. In spite of these concerns, it is unlikely the release of the CMS data will significantly impact the accessibility of a spine surgeon to a Medicare beneficiary.
- Centers for Medicare and Medicaid Services
- CMS
- Release of data
- Association for Collaborative Spine Research
- ACSR
Introduction
In April 2014, the Centers for Medicare and Medicaid Services (CMS) released a dataset for the public which included information on services provided by physicians and healthcare providers for Medicare beneficiaries in the 2012 calendar year (http://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trend…). According to the CMS, the purpose of the release was to “make our health-care system more transparent, affordable, and accountable.”1 However, as noted on the Medicare website, this data may not be entirely representative of a physician's practice, as only Medicare beneficiaries are included.1 The data is supplied in Microsoft Excel (Microsoft Corporation, Redmond, WA) spreadsheets, as well as a searchable database which includes the description of service, number of services provided, number of Medicare Beneficiaries, the average Medicare allowed amount, the average submitted charge amount, and the average Medicare payment amount. This financial data had previously been private information.
Numerous other sources have since utilized the data to create their own searchable databases, which take additional steps by calculating the total payment amounts to physicians. Multiple publications in the lay media resulted from the CMS data, including articles on the apparent small fraction of doctors who receive a large proportion of the Medicare payments and lists of “Best-Paid” doctors.2 Additionally, the New York Times identified multiple pitfalls in the interpretation of the released data, including that is does not take overhead or salaried employees into account; it does not correctly allocate money that is shared between physician, and it does not account for the complexity of patients treated.3 Failure of patients to understand the limitations of this published data can leave patients with a drastically altered view of different physicians.4
While improved transparency may provide patients with information to help decide which physician is best for them, how the current data will affect patient care is still unclear. The purpose of this study is to determine spine surgeons’ opinions on the release of the CMS data, and determine how they feel this information may affect patient care.
Methods
A survey was sent to members of the Association for Collaborative Spine Research (ACSR) regarding their practice patterns and opinions on the release of the CMS data. An in-person paper version was administered at the annual meeting, as well as an online version to members not at the meeting. Determinants included surgical subspecialty, practice setting, years in practice and region. Agreement or disagreement to statements was graded based on the following scale: strongly disagree, disagree, neutral, agree, and strongly agree. The average response was collected for each question and compared across groups. Additionally, questions in which greater than 75% of respondents either agreed (agree or strongly agree) or disagreed (disagree or strongly disagree) were identified.
Statistical Methods
A Kappa coefficient (κ) was used to assess the interobserver reliability of the respondents and was interpreted with the Landis and Koch grading system.5 This system defines slight agreement as a κ of less than 0.2, fair agreement as a κ between 0.4 and 0.6, substantial agreement as a κ between 0.6 and 0.8, and excellent agreement if the κ is greater than 0.8. Cochran's Q test was also used to identify whether responses had statistically distinct response rates based on the surgeons’ subspecialty, practice setting, years in practice or region. All statistical analyses were carried out in the statistical platform R 3.1.1 (R Foundation for Statistical Computing, Vienna Austria).
Results
A total of 353 surveys were sent out, and 76 surveys (21.5%) were completed; the demographics of the surgeons can be found in Table 1. All but three surgeons (95.7%) accept Medicare, and Table 2 demonstrates an estimate of the percentage of a spine surgeon's patients that are Medicare beneficiaries, and an estimate of the percentage of a spine surgeon's salary that comes from Medicare.
The average response (1 – strongly disagree; 2—disagree; 3—neutral; 4—agree; 5—strongly agree) for all questions is reported in Table 3, and while the overall intrerobserver reliability was only slight (κ = 0.11), more than 75% of respondents agreed or strongly agreed with five statements (Table 4), and more than 75% of respondents disagreed or strongly disagreed with six statements (Table 5). In the final question, surgeons were asked to identify all reasons they believe CMS released the financial data, and a significant (p < 0.001) percentage of surgeons (68.1%) believe identifying outliers abusing the system was one of the major reasons for the release of the CMS data (Figure 1).
Regression analysis was performed to determine if surgeon subspecialty, practice setting, years in practice or region affected the responses, but none were found to be statistically significant.
Discussion
The goal of this project was to determine spine surgeons’ opinions on the release of the CMS data, and determine how they feel this information may affect patient care. We identified a broad consensus that the release of this data will not help patients choose the best spine surgeon for them, with 95.7% of spine surgeons disagreeing with the statement: “The CMS data will help patients decide which spine surgeon is best for them.” Furthermore, 86.2% of surgeons disagreed that the data released will help patients identify surgeons with appropriate indications.
While spine surgeons’ felt the current methods for the release of financial data will have little benefit to patients, this is not because they are opposed to more transparency in healthcare. Over 86% of respondents are in favor of more transparency, but they feel the manor in which the data was released does not accurately portray spine surgery. Approximately 43% all Medicare payments are used to pay for fixed overhead, and an additional 9% will go to medical malpractice insurance for spine surgeons.4 Furthermore, the average medical student graduates with almost $200,000 in student loans that continue to accrue interests during the 6-8 years required to become a spine surgeon,6 and the opportunity cost associated with the decision to become a spine surgeon is even more substantial. Because the CMS data lacks the proper context, 83% of respondents felt the financial data does not accurately portray spine surgery.
Another limitation of the CMS data is the inability of the patient to determine the overall practice trends of a physician. This could result in two different scenarios for patients attempting to use the data: if the physician's practice does not include many Medicare patients, patients may believe that the surgeon is not busy or experienced due to low volume; on the other hand, if a surgeon's practice consists of a large proportion of Medicare patients, or the surgeon practices at a large referral center taking care of complex pathology, the surgeons may be viewed as overly aggressive with potentially inappropriate indications for surgery. Either scenario may not be accurate, but without the proper context the data may misinform patients. Misinterpretation of the data can easily be seen in the authors’ own practice, as the senior surgeons have a spent years developing a referral network that results in an increase in the treatment of younger patients; where as the referrals for the junior partners referrals often come from in hospital consultations of Medicare patients. Because of this, a patient reviewing the Medicare claims data may believe that the older surgeons are significantly less busy than the younger surgeons
On top of the concern that surgeons have for patients misinterpreting the data, 84.1% of surgeons believe the articles in the press do not present the data in an accurate way. One such example of this is when CBS News used the new data to identify surgeons performing a significant number of “controversial back surgeries,” and published a report on lumbar fusions.7 While few would argue that a lumbar fusion for isolated discogenic back pain is controversial, the report fails to discuss the many evidence-based reasons to perform a lumbar fusion.8, 9 The effectiveness, and cost-effectiveness of a lumbar fusion for degenerative spondylolisthesis has been well documented by classic studies10, 11 and by the Spine Patient Outcomes Research Trial (SPORT),8, 9 but rather than discussing appropriate indications for a lumbar fusion, the article attempts to scare viewers about the dangers of the procedure.7
In spite of the concerns that surgeons have with the release of the CMS data, it does not appear that the decision to release this data will jeopardize the access Medicare beneficiaries have to spine surgeons. Over 84% of spine surgeons reported a moral obligation to treat these patients, and 95% of surgeons disagreed with the statement: “I have stopped treating Medicare patients because of the release of this data.”
Limitations to this study exist, including that it is a survey of a small number of surgeons, of which a disproportionate number work in an academic institution. No statistical verification that either the 353 members of the ACSR was a representative subset of all spine surgeons or that the 21.5% of the ACRS members who chose to complete and return this questioner was a representative subset of the members of the ACSR. Thus, severe sampling bias could be contained in the results of this study and the results presented may not accurately reflect the opinions spine surgeons in general. The results presented here are the opinions of 76 academically oriented spine surgeons, and it is possible that these surgeons may have considerably different views from the rest of the spine surgeons; however while undoubtedly the respondents of this survey are more academic than the average spine surgeon, there is significant diversity in the respondents, as they are from all over the country, differing specialties and differing experience. Nonetheless, the results of this survey may not be representative of all spine surgeons. Furthermore, the overall agreement was only slight (κ = 0.11), so while there was substantial consensus on 11 questions, it is difficult to interpret the results of the other questions.
A further limitation to this study is that it reports the opinions of spine surgeons not of patients. While this allowed us to accomplish one of the major goals of the study, which was to determine if the release of the CMS data would affect accessibility of a spine surgeon to a Medicare beneficiary, it does not determine if patients had an understanding of, or ability to, interpret the released data, or if the data released affective patient selection of a surgeon.
Conclusion
Spine surgeons are in favor of more transparency in healthcare, but they do not feel the release of the CMS data will help patients better identify the appropriate surgeon to treat their spinal pathology. Similarly, they feel that without appropriate context, the released data fails to accurately represent spine surgeons. In spite of the concerns spine surgeons have about the release of the CMS data, it is unlikely that the release of data will significantly impact the accessibility of a spine surgeon to a Medicare beneficiary.
Disclosures
This work was supported by The Association for Collaborative Spine Research. Gregory Schroeder has received funding from Medtronic for travel to meetings. John Koerner has received research support from Medtronic. Paul Arnold has acted as consultant for Medtronic, Stryker, FizoMed, AOSpine, Life Spine, Intgra Life, Spine Wave, MIEMS, Cerapedics and has stocks in Zplasty. Robert Isaacs is on the board of Saferay Spine; has acted as consultant for NuVasive, Baxano, Vertera; has received grants and royalties from NuVasive; has stocks in Providence, Saferay Spine, SafeWire, Vertera, Vilaspine; has received travel compensation from Verter and the ACSR and has acted as scientific advisor to Vertera. Alan Hilibrand has received royalties from Aesculap/B.Braun, Amedica, Biomet, and Stryker, and owns stocks in Amedica, Benvenue Medical, Lifespine, Nexgen, Paradigm Spine, PSD, Spinal Ventures, and Vertiflex. Alex Vaccaro has acted as consultant for Medtronic, Stryker, Globus, Stout, Gerson Lehrman Group, Guidepoint Global, Medacorp, Innovative Surgical Design, Orthobullets, has performed expert testimony for Ellipse; serves on advisory boards or committees for Innovative Surgical Design, and Spinicity; has received royalties from Thieme, Jaypee, Elsevier, Taylor Francis, Aesculap, Globus, Medtronic, Stryker, DePuy; has received institutional support from Cerapedics; owns stocks in Spine Medica, Computational Biodynamics, Progressive Spinal Technologies, Spinology, Small Bone Innovations, Cross Current, In Vivo, Flagship Surgical, Advanced Spinal Intellectual Properties, Cytonics, Bonovo Orthopaedics, Electrocore, Gamma Spine, Location Based Intelligence, FlowPharma, R.S.I., Replication Medica, Globus, Stout Medical, Rothman Institute and Related Properties, Innovative Surgical Design, and Spinicity. Kris Radcliff has consulted for Depuy, Medtronic, LDR Spine, Globus; received grants from DePuy, Medtronic, Paradigm Spine; received royalties from Globus; and has been given travel support by Globus, AOSpine, Stryker, DePuy.
- Copyright © 2015 ISASS - This manuscript is generously published free of charge by ISASS, the International Society for the Advancement of Spine Surgery